Cosmo Pharmaceuticals NV has announced the initiation of a groundbreaking clinical study set to begin in July 2025. The study will assess the usability of a new medical device software application that integrates the Medtronic GI Genius™ intelligent endoscopy module with Apple Vision Pro. This study will take place at Rush University Medical Center in Chicago under the supervision of Dr. Irving Waxman. The research aims to evaluate the real-time application of this technology during colonoscopy procedures. The outcomes of this study are intended to be a significant part of Cosmo's upcoming FDA submission. Results from the study have not yet been presented.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.